Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | F2 | P00734 | 1/20 | 0.34 |
| ▸ | AVPR1B | P47901 | 6/20 | 0.33 |
| ▸ | AVPR1A | P37288 | 1/20 | 0.33 |
| ▸ | NMT1 | P30419 | 2/20 | 0.32 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.32 |
| ▸ | TSHR | P16473 | 1/20 | 0.31 |
| ▸ | PTGDR2 | Q9Y5Y4 | 1/20 | 0.31 |
| ▸ | MAPT | P10636 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL492918 | 0.91 | F2 (0.39) | F2AVPR1BAVPR1ANMT1EPHX2 | |
| SCHEMBL4084741 | 0.80 | BDKRB1 (0.43) | — | |
| SCHEMBL571406 | 0.77 | BDKRB1 (0.37) | TSHR | |
| SCHEMBL15347788 | 0.76 | BDKRB1 (0.37) | TSHR | |
| SCHEMBL4461535 | 0.75 | FABP4 (0.43) | F2EPHX2MAPT | |
| SCHEMBL4781829 | 0.74 | BDKRB1 (0.36) | — | |
| SCHEMBL5087475 | 0.72 | F2 (0.40) | F2AVPR1BAVPR1ANMT1EPHX2 | |
| SCHEMBL493488 | 0.71 | NPSR1 (0.46) | TSHR | |
| SCHEMBL4475594 | 0.71 | KDM4E (0.40) | TSHRPTGDR2MAPT | |
| SCHEMBL5130040 | 0.71 | MEN1 (0.39) | EPHX2TSHRPTGDR2MAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8263598-B2 | Substituted sulfonamide compounds | GRUENENTHAL GMBH (DE) | 2012-09-11 | — | — | US | disclosed |
| US-20090186899-A1 | Substituted Sulfonamide Compounds | GRUENENTHAL GMBH (DE) | 2009-07-23 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090186899-A1 | Substituted Sulfonamide Compounds | BDKRB1, BDKRB2, NPSR1 | F2 188/4885AVPR1B 64/4885AVPR1A 63/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.